10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JPMORGAN CHASE & CO | |||
Ticker: AMJ Fiscal Year: 2022 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2022 10-K (Filed: Feb 21, 2023) | |||
| (In Millions, except shares in Thousands) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
| Revenue | |||
| Investment banking fees | $ 6,686 | 13,216 | 9,486 |
| Principal transactions | 19,912 | 16,304 | 18,021 |
| Lending- and deposit-related fees | 7,098 | 7,032 | 6,511 |
| Asset management, administration and commissions | 20,677 | 21,029 | 18,177 |
| Investment securities gains/(losses) | (2,380) | (345) | 802 |
| Mortgage fees and related income | 1,250 | 2,170 | 3,091 |
| Card income | 4,420 | 5,102 | 4,435 |
| Other income | 4,322 | 4,830 | 4,865 |
| Noninterest revenue | 61,985 | 69,338 | 65,388 |
| Interest income | 92,807 | 57,864 | 64,523 |
| Interest expense | 26,097 | 5,553 | 9,960 |
| Net interest income | 66,710 | 52,311 | 54,563 |
| Total net revenue | 128,695 | 121,649 | 119,951 |
| Provision for credit losses | 6,389 | (9,256) | 17,480 |
| Noninterest expense | |||
| Compensation expense | 41,636 | 38,567 | 34,988 |
| Occupancy expense | 4,696 | 4,516 | 4,449 |
| Technology, communications and equipment expense | 9,358 | 9,941 | 10,338 |
| Professional and outside services | 10,174 | 9,814 | 8,464 |
| Marketing | 3,911 | 3,036 | 2,476 |
| Other expense | 6,365 | 5,469 | 5,941 |
| Total noninterest expense | 76,140 | 71,343 | 66,656 |
| Income/(loss) before income tax expense/(benefit) | 46,166 | 59,562 | 35,815 |
| Income tax expense | 8,490 | 11,228 | 6,684 |
| Net income/(loss) | 37,676 | 48,334 | 29,131 |
| Basic net income applicable to common stockholders | 35,892 | 46,503 | 27,410 |
| Diluted net income applicable to common stockholders | 35,892 | 46,503 | 27,410 |
| Net income per common share data | |||
| Basic earnings per share (in dollars per share) | 12.10 | 15.39 | 8.89 |
| Diluted earnings per share (in dollars per share) | 12.09 | 15.36 | 8.88 |
| Weighted-average basic shares (in shares) | 2,965,800 | 3,021,500 | 3,082,400 |
| Weighted-average diluted shares (in shares) | 2,970,000 | 3,026,600 | 3,087,400 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JPMORGAN CHASE & CO | |||
Ticker: AMJ Fiscal Year: 2022 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2022 10-K (Filed: Feb 21, 2023) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
| Net income | $ 37,676 | 48,334 | 29,131 |
| Other comprehensive income/(loss), aftertax | |||
| Unrealized gains/(losses) on investment securities | (11,764) | (5,540) | 4,123 |
| Translation adjustments, net of hedges | (611) | (461) | 234 |
| Fair value hedges | 98 | (19) | 19 |
| Cash flow hedges | (5,360) | (2,679) | 2,320 |
| Defined benefit pension and OPEB plans | (1,241) | 922 | 212 |
| DVA on fair value option elected liabilities | 1,621 | (293) | (491) |
| Total other comprehensive income/(loss), aftertax | (17,257) | (8,070) | 6,417 |
| Comprehensive income | 20,419 | 40,264 | 35,548 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JPMORGAN CHASE & CO | |||
Ticker: AMJ Fiscal Year: 2022 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2022 10-K (Filed: Feb 21, 2023) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
| Operating activities | |||
| Net income | $ 37,676 | 48,334 | 29,131 |
| Adjustments to reconcile net income to net cash provided by/(used in) operating activities: | |||
| Provision for credit losses | 6,389 | (9,256) | 17,480 |
| Depreciation and amortization | 7,051 | 7,932 | 8,614 |
| Deferred tax (benefit)/expense | (2,738) | 3,748 | (3,573) |
| Other | 5,174 | 3,274 | 1,649 |
| Originations and purchases of loans held-for-sale | (149,167) | (347,864) | (166,504) |
| Proceeds from sales, securitizations and paydowns of loans held-for-sale | 167,709 | 336,413 | 175,490 |
| Net change in: | |||
| Trading assets | (31,449) | 85,710 | (148,749) |
| Securities borrowed | 20,203 | (45,635) | (20,734) |
| Accrued interest and accounts receivable | (22,970) | (12,401) | (18,012) |
| Other assets | (2,882) | (11,745) | (42,430) |
| Trading liabilities | 11,170 | (23,190) | 77,198 |
| Accounts payable and other liabilities | 58,614 | 43,162 | 7,415 |
| Other operating adjustments | 2,339 | (398) | 3,115 |
| Net cash provided by/(used in) operating activities | 107,119 | 78,084 | (79,910) |
| Investing activities | |||
| Net change in: | |||
| Federal funds sold and securities purchased under resale agreements | (54,278) | 34,473 | (47,115) |
| Held-to-maturity securities: | |||
| Proceeds from paydowns and maturities | 48,626 | 50,897 | 21,360 |
| Purchases | (33,676) | (111,756) | (12,400) |
| Available-for-sale securities: | |||
| Proceeds from paydowns and maturities | 39,159 | 50,075 | 57,675 |
| Proceeds from sales | 84,616 | 162,748 | 149,758 |
| Purchases | (126,258) | (248,785) | (397,145) |
| Proceeds from sales and securitizations of loans held-for-investment | 44,892 | 35,845 | 23,559 |
| Other changes in loans, net | (128,968) | (91,797) | (50,263) |
| All other investing activities, net | (11,932) | (11,044) | (7,341) |
| Net cash (used in) investing activities | (137,819) | (129,344) | (261,912) |
| Financing activities | |||
| Net change in: | |||
| Deposits | (136,895) | 293,764 | 602,765 |
| Federal funds purchased and securities loaned or sold under repurchase agreements | 8,455 | (20,799) | 31,528 |
| Short-term borrowings | (8,984) | ||
| Short-term borrowings | 7,773 | 4,438 | |
| Beneficial interests issued by consolidated VIEs | 2,205 | (4,254) | 1,347 |
| Proceeds from long-term borrowings | 78,442 | 82,409 | 78,686 |
| Payments of long-term borrowings | (45,556) | (54,932) | (105,055) |
| Proceeds from issuance of preferred stock | 0 | 7,350 | 4,500 |
| Redemption of preferred stock | (7,434) | (2,575) | (1,430) |
| Treasury stock repurchased | (3,162) | (18,408) | (6,517) |
| Dividends paid | (13,562) | (12,858) | (12,690) |
| All other financing activities, net | 234 | (1,477) | (927) |
| Net cash provided by/(used in) financing activities | (126,257) | 275,993 | 596,645 |
| Effect of exchange rate changes on cash and due from banks and deposits with banks | (16,643) | (11,508) | 9,155 |
| Net increase/(decrease) in cash and due from banks and deposits with banks | (173,600) | 213,225 | 263,978 |
| Cash and due from banks and deposits with banks at the beginning of the period | 740,834 | 527,609 | |
| Cash and due from banks and deposits with banks at the end of the period | 567,234 | 740,834 | 527,609 |
| Cash interest paid | 23,143 | 5,142 | 13,077 |
| Cash income taxes paid, net | 4,355 | 18,737 | 8,140 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
JPMORGAN CHASE & CO | ||
Ticker: AMJ Fiscal Year: 2022 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2022 10-K (Filed: Feb 21, 2023) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2022 | Dec 31, 2021 | |
| Assets | ||
| Cash and due from banks | $ 27,697 | 26,438 |
| Deposits with banks | 539,537 | 714,396 |
| Federal funds sold and securities purchased under resale agreements (included $311,883 and $252,720 at fair value) | 315,592 | 261,698 |
| Securities borrowed (included $70,041 and $81,463 at fair value) | 185,369 | 206,071 |
| Trading assets (included assets pledged of $93,687 and $102,710) | 453,799 | 433,575 |
| Available-for-sale securities (amortized cost of $216,188 and $308,254; included assets pledged of $9,158 and $18,268) | 205,857 | 308,525 |
| Held-to-maturity securities | 425,305 | 363,707 |
| Investment securities, net of allowance for credit losses | 631,162 | 672,232 |
| Loans (included $42,079 and $58,820 at fair value) | 1,135,647 | 1,077,714 |
| Allowance for loan losses | (19,726) | (16,386) |
| Loans, net of allowance for loan losses | 1,115,921 | 1,061,328 |
| Accrued interest and accounts receivable | 125,189 | 102,570 |
| Premises and equipment | 27,734 | 27,070 |
| Goodwill, MSRs and other intangible assets | 60,859 | 56,691 |
| Other assets (included $14,921 and $14,753 at fair value and assets pledged of $7,998 and $5,298) | 182,884 | 181,498 |
| Total assets | 3,665,743 | 3,743,567 |
| Liabilities | ||
| Deposits (included $28,620 and $11,333 at fair value) | 2,340,179 | 2,462,303 |
| Federal funds purchased and securities loaned or sold under repurchase agreements (included $151,999 and $126,435 at fair value) | 202,613 | 194,340 |
| Short-term borrowings (included $15,792 and $20,015 at fair value) | 44,027 | 53,594 |
| Trading liabilities | 177,976 | 164,693 |
| Accounts payable and other liabilities (included $7,038 and $5,651 at fair value) | 300,141 | 262,755 |
| Beneficial interests issued by consolidated VIEs (included $5 and $12 at fair value) | 12,610 | 10,750 |
| Long-term debt (included $72,281 and $74,934 at fair value) | 295,865 | 301,005 |
| Total liabilities | 3,373,411 | 3,449,440 [1] |
| Commitments and contingencies (refer to Notes 28, 29 and 30) | ||
| Stockholders equity | ||
| Preferred stock ($1 par value; authorized 200,000,000 shares: issued 2,740,375 and 3,483,750 shares) | 27,404 | 34,838 |
| Common stock ($1 par value; authorized 9,000,000,000 shares; issued 4,104,933,895 shares) | 4,105 | 4,105 |
| Additional paid-in capital | 89,044 | 88,415 |
| Retained earnings | 296,456 | 272,268 |
| Accumulated other comprehensive losses | (17,341) | (84) |
| Treasury stock, at cost (1,170,676,094 and 1,160,784,750 shares) | (107,336) | (105,415) |
| Total stockholders equity | 292,332 | 294,127 |
| Total liabilities and stockholders equity | 3,665,743 | 3,743,567 |
| Consolidated Entities | ||
| VIEs consolidated by the Firm | ||
| Trading assets (included assets pledged of $93,687 and $102,710) | 2,151 | 2,010 |
| Loans, net of allowance for loan losses | 34,411 | 33,024 |
| Other assets (included $14,921 and $14,753 at fair value and assets pledged of $7,998 and $5,298) | 550 | 490 |
| Total assets | 37,112 | 35,524 |
| Beneficial interests issued by consolidated VIEs (included $5 and $12 at fair value) | 12,610 | 10,750 |
| All other liabilities | 279 | 245 |
| Total liabilities | 12,889 | 10,995 |
| [1] The following table presents information on assets and liabilities related to VIEs that are consolidated by the Firm at December 31, 2022 and 2021. The assets of the consolidated VIEs are used to settle the liabilities of those entities. The holders of the beneficial interests do not have recourse to the general credit of JPMorgan Chase. The assets and liabilities in the table below include third-party assets and liabilities of consolidated VIEs and exclude intercompany balances that eliminate in consolidat | ||
| External Links | |
| JPMORGAN CHASE & CO (AMJ) Fiscal Year 2022 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |